Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-10-30

Clinical Trial Update: Tolvaptan for Hyponatremia in Cirrhotic Patients With Ascites [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update investigating tolvaptan for hyponatremia in cirrhotic patients with ascites.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Samsca (tolvaptan) (tolvaptan)

Snippet

Sponsor: Konkuk University Medical Center | Conditions: Hyponatremia, Ascites | Phase 4 | Status: UNKNOWN